eMed Commitment Program - Terms & Conditions

1. Commitment Program; Program Fees. When you sign up for the service you are agreeing to a twelve (12) month commitment program designed to support sustained health outcomes (“Commitment Program”). As an limited time offer, in exchange for you agreeing to provide your time in engaging in certain activities (outlined below) eMed will waive the program membership fee of $139.00 per month, or $1.668.00 a year (“Membership Fees”), you (meaning the participant in the Commitment Program) agree to remain enrolled in the Commitment Program for the full first 12-month term, subject to the cancellation rights described below (“First Year”). Program membership fees will be billed monthly, but will be waived during the First Year, contingent upon your fulfillment of the commitments described below, except where early termination is permitted under these Terms. The enrollment period for the limited time offer (where the Program Fees are waived) is currently scheduled to end on February 28, 2026, unless extended by eMed, in its sole discretion. Your enrollment in the Commitment Program is subject to the “Preauthorized Payment Terms” set forth in Exhibit A hereto. Please read carefully and contact eMed if you have any questions.

‍

2. Participation Requirements. Termination.

In exchange for waiving the Program Fees, you agree to provide the following:
1. A. Complete accurately and completely the Monthly Refill Prescription Form;
2. B. Complete at least one of four weekly medication check-ins per month; and,
3. C. Completion of six month and twelve-month blood work.

If you do not complete any of the following, your enrollment in the Commitment Program may be terminated. eMed will provide you two notices regarding any failure to complete any or all of the above. If after such notices, you have not come into compliance within an agreed upon period, then your enrollment in the Commitment Program will be terminated and you will owe the Termination Fees set forth in Section 8 below.

‍

3. Renewal. eMed reserves the right to continue, modify or discontinue the Commitment Program after the First Year. At least thirty (30) days prior to the end of the First Year, eMed will notify you about whether it will continue the Commitment Program, modify it, or discontinue it. It will provide you an opportunity to opt-in to the a renewal. If the Commitment Program continues and you opt-in, you will be agreeing to the same requirements (or modified requirements, as applicable) of the Commitment Program.

4. Medication Costs and Billing Authorization. Membership Fees and the cost of medication are separate and distinct charges. While program membership fees are waived during the Commitment Program, any prescription medication provided or arranged through the Commitment Program is not included and will be billed separately. By enrolling in the Commitment Program, Participant authorizes eMed to charge your credit card on file for all medication-related costs (medication and dispensing) as set forth below in Section 10, together with all other incidental costs shipping, and applicable taxes associated with the delivery of the medication (“Medication Costs”). The total price of the medication and incidental charges will be presented to you at the time eMed invoices you for the medication fill. Medication charges may vary based on prescription, dosage, duration, clinical adjustments and cost at time of purchase (eMed will update the prices as the medication cost changes). All medication charges are non-refundable once dispensed, except as required by law. If you do not agree to the total price of the medication and incidental charges, you must notify eMed.

‍

5. Medication Use, Clinical Autonomy and Reauthorization. Any prescription medication made available through the Commitment Program is prescribed and managed solely by a licensed clinician, in the exercise of independent medical judgment and based on your consent. Medication initiation, adjustment, or discontinuation may occur at any time as clinically appropriate. If medication is discontinued pursuant to clinician direction, the Commitment Program does not automatically terminate. You may continue to receive non-medication Commitment Program Services for the remainder of the commitment term. At least every six months (or prior to a change in dosage), the licensed clinician managing your participation in the Commitment Program will issue a new prescription for your continued participation. If a new prescription is issued, you authorize us to continue to ship the medication to you as a part of the Commitment Program. You further agree to complete all necessary steps required by the licensed clinician. If you do not complete the required steps, and the licensed clinician does not provide the reauthorization, you will be subject to the Early Termination Fee provided in Section 5 if you are still within the Introductory Period.

‍

6. Early Termination; Reimbursement Obligation. You may terminate your participation in the Commitment Program at any time by emailing eMed at support@emed.com, calling eMed toll-free at 1-800-682-2829, or mailing a termination letter to eMed. If you voluntarily withdraw from the Commitment Program without an approved reason as provided in section 5 prior to completion of the Introductory Period , eMed will charge a cancellation fee equal to three months of the waived Membership Fees or $417.00 (“Termination Fee”). Terminating your participation in the Commitment Program does not relieve you of your obligation to pay for medication dispensed to you prior to cancellation or that is already dispensed (but may not have been received) prior to cancellation. eMed does not advise terminating the use of the medication, without proper tapering off in accordance with the advice of your physician. If your enrollment in the Commitment Program is terminated as a result of not complying with the Program requirements in Section 2, then eMed will continue to fill your medication for one month after your termination of the Program.

‍

7. Permitted Cancellations; Fee Waivers. Notwithstanding the foregoing, eMed will waive any Termination Fee, in whole or in part, without penalty, under the following circumstances:

a. Medical Necessity or Safety

documented medical necessity, adverse events, or safety concerns;
clinical determination that continued participation or treatment is contraindicated; or
healthcare provider recommendation to discontinue participation.

b. Financial Hardship

a material, unanticipated change in financial circumstances, including job loss, significant income reduction, or comparable hardship.

c. Loss of Eligibility or Service Availability

relocation or change in circumstances rendering the Participant ineligible for, or unable to receive, Program services due to regulatory, clinical, or operational limitations.

d. Substantial Increase in Costs

an increase in the costs of medications such that the total price is at least more than 20% of the potential costs that were disclosed to you at the time that you agreed to terms of the Commitment Program.

Determinations under this section shall be made reasonably and in eMed’s good faith, and eMed may request, from you, supporting documentation where appropriate.

‍

8. Data Use; Population Health Insights; Informed Consent. By enrolling in the Commitment Program, you consent to the collection and use of your data in a de-identified, anonymized, and aggregated form for population health insights, observational analysis, and program improvement, consistent with our privacy policy.

‍

9. Modifications. eMed reserves the right to modify these Terms at any time. Material changes shall not retroactively affect fulfilled commitments or approved early terminations.

‍

10. All Other Terms. All other terms of your use of eMed’s Services are set forth at https://web.us.emed.com/terms.

‍

11. Comments, Questions, Concerns. If you have any comments, questions or concerns, please direct them support@emed.com and eMed will work in good faith to get you a timely response.

‍

12. Drug Pricing.

Wegovy — Single-Use Pens (4-pack):

0.25 mg: $199 (introductory; increases to $349 after 2 fills)
0.5 mg: $199 (introductory; increases to $349 after 2 fills)
1.0 mg: $349
1.7 mg: $349
2.4 mg: $349

Wegovy — Oral Tablets (Pills):

1.5 mg: $149
4 mg: $149 (introductory; increases to $199 after April 15, 2026)
9 mg: $299
25 mg: $299

‍

EXHIBIT A

Preauthorized Payment Agreement

By clicking I agree at checkout, I (“Patient”)

‍

Authorize eMed, or any of its related or affiliated entities, including their successors, assigns, agents and service providers (collectively, “eMed” or the “Company”) to initiate electronic debits or charges to my provided account(s) via my credit card account(s (“Payment Method”), or from any substitute account which I later specify or my financial institution later provides,
- immediately in the amount of $49, as a one-time fee for my initial telehealth consultation;
- at the time eMed invoices me for my medication fill in the total amount of my applicable Medication Costs, as detailed in the Terms & Conditions, and any agreement related thereto, or in any alternative amounts or dates to which I and Company subsequently agree in writing

Promise that the Payment Method is legitimate, open and active, and that I am an authorized signer on it.

Understand, acknowledge, and agree that:

This is a continuing authorization which will remain in full force and effective until the earlier of (1) Patient’s withdrawal of consent to these automatic recurring charges (which may be made at any time), or (2) the expiration of Patient’s account;
‍
If any single charge is refused/dishonored, such amount is immediately due and payable from Patient and the failure to pay such amount may result in the cancellation of services as described in the Terms of Service.
‍
If the payment due date authorized herein falls on a weekend or holiday, I understand that the payment may be executed on the next business day. I understand that because this is an electronic transaction, these funds may be withdrawn from my account or charged to my credit card as soon as the transaction date. Any transaction rejected for Non-Sufficient Funds (NSF) will be subject to a fee of up to $25.00 (as permitted by law with such fees being determined by the state in which I reside) initiated as a separate transaction. If the amount due is not timely paid, my service may be cancelled, as set forth in the Terms and Conditions. Should I incur an NSF fee, I authorize eMed to electronically debit or charge the Payment Method for such fee. I understand that eMed may at its discretion attempt to reinitiate any rejected or unsuccessful charge up to two times. I understand that my financial institution may impose fees in connection with rejected payments, and I agree that eMed does not have any liability for such fees.
‍
In the event that eMed makes an error in processing a payment, I authorize Company to correct the error by crediting or debiting my Payment Method in the amount of such error on or after the date such error occurs. If there is any missing or erroneous information with respect to the Payment Method or the associated financial institution, I authorize eMed to verify and correct such information..
‍
This is a continuing authorization which will remain in full force and effective until the earlier of (i) my withdrawal of consent to these automatic recurring credit card charges (which may be made at any time), or (ii) the expiration of my membership in the Commitment Program;
‍
This authorization may be withdrawn either emailing eMed at support@emed.com, calling eMed toll-free at 1-800-682-2829, or mailing a termination letter to eMed. I understand that this authorization in no way limits any right I may have under federal law to stop payment of a preauthorized electronic transfer by contacting my financial institution. I agree to notify Company in writing at the address above of any changes to my Payment Method, or termination of this authorization, at least three 14 days prior to the next billing date.
‍
Company reserves the right to terminate this payment plan or Patient’s participation therein at any time. If Patient revokes authorization or Company terminates recurring electronic payments, Patient understands Patient is responsible for making payments by another payment method. Terminating this authorization does not affect Patient’s duty to repay Patient’s underlying obligation. Patient also hereby authorizes Company to update the Payment Method details with information received from any card or account updating services.
‍
The origination of ACH transactions and electronic transactions must comply with the provisions of U.S. law and applicable network rules. Each payment will be processed in U.S. dollars, and, if it is converted into another currency, its amount may vary based on fluctuations in the applicable conversion rate.
‍
This agreement becomes effective for the next scheduled payment upon receipt of the signed agreement. Please allow up to seven (7) business days for processing.

‍

BY (ELECTRONICALLY SIGNING/CLICKING “I AGREE”) YOU ARE AGREEING TO THIS PREAUTHORIZED PAYMENT AGREEMENT. YOU ACKNOWLEDGE THAT YOU HAVE READ, PRINTED/SAVED, UNDERSTAND, AND AGREE TO BE BOUND BY THE TERMS OF THIS AGREEMENT.

‍‍

Last Updated: February 3, 2026

‍